Revelation Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $26 | $0 | $0 | $0 |
Gross Profit | 13 | -7 | -6 | |
EBITDA | -15,025,243 | -1,789 | -2,515 | -1,895 |
EBIT | -15,025,223 | -1,796 | -2,522 | -1,902 |
Net Income | -15,025,223 | -2,241 | -8,389 | -2,681 |
Net Change In Cash | 26 | 0 | 0 | 0 |
Free Cash Flow | -18,320,854 | -14,256 | -2,497 | -2,857 |
Cash | 6,499,018 | 6,541 | 12,073 | 14,551 |
Basic Shares | 1,715 | 2,679 | 1,635 | 1,089 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -25 | -40 | -69 |
EBITDA | -95 | -10,839 | -11,933 |
EBIT | -120 | -10,879 | -12,002 |
Net Income | -120 | -10,794 | -11,986 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -7,286 | -11,219 | -11,222 |
Cash | 11,991 | 5,252 | 1,274 |
Basic Shares | 228 | 17 | 9 |
